Skip to main content
. 2020 Nov 2;21(1):4. doi: 10.3892/etm.2020.9436

Figure 3.

Figure 3

PSD95 interaction with NR2B and nNOS following Dex treatment. (A) Dex treatment reduced PSD95 interaction with NR2B and nNOS as presented by immunoprecipitation assay. (B) Relative levels of nNOS and NR2B immunoprecipitated with PSD95 and normalized to the Veh group. Data were represented as the means ± standard error of the mean. *P<0.05 vs. Veh. Dex, dexmedetomidine; IgG, immunoglobulin G; kD, kilodalton; nNOS, neuronal nitric oxide synthase; NR2B, N-methyl-D-aspartic acid receptor subunit; PSD95, post-synaptic density 95; TBI, traumatic brain injury; Veh, vehicle.